Cargando…
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
End-stage renal disease (ESRD) patients have a higher prevalence of diabetes mellitus, hypertension, congestive heart failure and advanced age, along with an increased incidence of non-valvular atrial fibrillation (AF), thereby increasing the risk for cerebrovascular accidents. Systemic anticoagulat...
Autores principales: | Goel, Narender, Jain, Deepika, Haddad, Danny B., Shanbhogue, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568986/ https://www.ncbi.nlm.nih.gov/pubmed/33053946 http://dx.doi.org/10.5853/jos.2020.01886 |
Ejemplares similares
-
Choice of dialysis modality prior to kidney transplantation: Does it matter?
por: Jain, Deepika, et al.
Publicado: (2019) -
Hemoperitoneum After Cardiopulmonary Resuscitation in Peritoneal Dialysis Patients: A Tale of Two Cases
por: Goel, Narender, et al.
Publicado: (2020) -
Atrial fibrillation mimicking ventricular fibrillation confuses an automated external defibrillator
por: Hulleman, M., et al.
Publicado: (2018) -
Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
por: Königsbrügge, Oliver, et al.
Publicado: (2019) -
Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry
por: Yamamoto, Tasuku, et al.
Publicado: (2023)